Literature DB >> 11523483

Cancer support groups: meeting the needs of African Americans with cancer.

F K Barg1, M M Gullatte.   

Abstract

OBJECTIVES: To describe culturally appropriate ways that cancer support groups can meet the needs of African Americans with cancer. DATA SOURCES: Research articles and clinical experience.
CONCLUSIONS: Support groups are an important vehicle through which people cope with the emotional and physical impact of their cancer. Most support group participants are middle-class, white women. Faith-based cancer support groups can address the needs of many African Americans with cancer by offering support and education within the context of a spiritually based life-style. IMPLICATIONS FOR NURSING PRACTICE: Coping strategies may vary among cultural groups. In order to be supportive, cancer support groups must be congruent with the values and beliefs of the group's members.

Entities:  

Mesh:

Year:  2001        PMID: 11523483     DOI: 10.1053/sonu.2001.25946

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  10 in total

Review 1.  Spiritual assessment in African-Americans: a review of measures of spirituality used in health research.

Authors:  Lisa M Lewis
Journal:  J Relig Health       Date:  2008-12

Review 2.  Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Danielle B Rice; Alexander W Levis; Lorie A Kloda; Annett Körner; Brett D Thombs
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

3.  Participant evaluation of teleconference support for African American women with breast cancer.

Authors:  Sue P Heiney; Swann Arp Adams; Linda M Wells; Hiluv Johnson; Jennifer M King
Journal:  Cancer Nurs       Date:  2012 Mar-Apr       Impact factor: 2.592

4.  They lift my spirit up: stakeholders' perspectives on support teams for African Americans facing serious illness.

Authors:  LeRon C Jackson; Laura C Hanson; Michelle Hayes; Melissa Green; Stacie Peacock; Giselle Corbie-Smith
Journal:  Health Educ Behav       Date:  2014-04-09

5.  Development and preliminary validation of the Scleroderma Support Group Leader Self-efficacy Scale.

Authors:  Nicole E Pal; Stephanie T Gumuchian; Vanessa C Delisle; Mia Pépin; Vanessa L Malcarne; Marie-Eve Carrier; Linda Kwakkenbos; Sandra Peláez; Ghassan El-Baalbaki; Brett D Thombs
Journal:  J Scleroderma Relat Disord       Date:  2017-09-25

Review 6.  Breast cancer experience and survivorship among Asian Americans: a systematic review.

Authors:  Kuang-Yi Wen; Carolyn Y Fang; Grace X Ma
Journal:  J Cancer Surviv       Date:  2013-11-09       Impact factor: 4.442

7.  Characteristics of psychosocial support seeking during HIV-related treatment in western Kenya.

Authors:  Enbal Shacham; Michael Reece; Willis Owino Ong'or; Otieno Omollo; Patrick O Monahan; Claris Ojwang
Journal:  AIDS Patient Care STDS       Date:  2008-07       Impact factor: 5.078

Review 8.  Understanding the nature and role of spirituality in relation to medication adherence: a proposed conceptual model.

Authors:  Lisa M Lewis; Gbenga Ogedegbe
Journal:  Holist Nurs Pract       Date:  2008 Sep-Oct       Impact factor: 1.000

Review 9.  Effect of support group peer facilitator training programmes on peer facilitator and support group member outcomes: a systematic review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Lorie A Kloda; Jill Boruff; Ghassan El-Baalbaki; Annett Körner; Vanessa L Malcarne; Brett D Thombs
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

10.  Scleroderma Patient-centered Intervention Network-Scleroderma Support group Leader EDucation (SPIN-SSLED) program: non-randomised feasibility trial.

Authors:  Brett D Thombs; Laura Dyas; Mia Pépin; Kylene Aguila; Marie-Eve Carrier; Lydia Tao; Sami Harb; Vanessa L Malcarne; Ghassan El-Baalbaki; Sandra Peláez; Maureen Sauve; Marie Hudson; Robert W Platt
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.